Reference: JVM200625A

Our client is an award-winning entrepreneurial pharmaceutical company working to drive change in rare diseases.  They are seeking an experienced Clinical Director to lead the finalisation and execution of a Phase 2 clinical programme.

The role holder will:

• Finalise Phase 2 protocol, endpoints, and regulatory strategy
• Align clinical documentation to investor- and regulator-ready standard
• Support fundraising and grant applications
• Lead CRO selection and trial readiness

The role demands an MD/PhD with Phase 2 clinical development experience. Strong regulatory insight (FDA/EMA; is required; rare disease expertise is desirable). The role holder must be hands-on, detail-oriented, and execution-focused and comfortable operating in a lean, fast-moving environment.

The role is initially part-time (equity/deferred payment), moving to paid role post-funding with potential to scale to full-time.

A full brief is available on request.